GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for ...

In today's volatile and uncertain environment, organisations and their leaders in Nigeria are confronted with a complex web of strategic challenges that demand more than operational excellence ...

Recent developments illustrate dynamic shifts in the healthcare sector. Trump's spending bill is anticipated to challenge ...

GSK has shifted towards a global marketing model influenced by a Netflix-style approach that aims to match content to the person receiving it. Richard Staines heard about this new strategy at the ...

Each of our versions of reality is changing with AI. This could erode our ability to agree on basic facts or navigate shared challenges.

Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

Britain's life sciences sector plan receives a mixed reception from the pharmaceutical industry. While the strategy aims to boost R&D, industry leaders criticize the lack of resolution on drug pricing ...

Real-world deployment patterns show customers using multiple AI models simultaneously, forcing a fundamental shift in enterprise AI architecture.

At e4m TechManch 2025, CX leaders across telecom, retail, pharma, and tech explored how AI, data, and design are redefining ...

UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.